CLINICAL ROLE -
Turning the focus to non-statin therapies, the panel outlines logistical barriers and discusses the characteristics that guide treatment selection in patients with ASCVD.
Zilebesiran Offers An RNA Interference Therapeutic Agent for Hypertension
CDC Report Finds US Residents in Rural Areas Face Higher Percentages of Preventable Premature Deaths
Managing Pulmonary Arterial Hypertension: Diagnosis, Classification, and Treatment Strategies
Study Finds Many Individuals With Cardiovascular Disease Consume Twice Daily Recommendation of Sodium
Semaglutide's New Indication Highlights Growing Role of GLP-1 Receptor Agonists
SGLT-2 Inhibitors Associated with Reduced Hyperkalemia in Patients With Heart Failure